KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Liabilities from Discontinued Operations (2016)

Historic Liabilities from Discontinued Operations for Abbott Laboratories (ABT) over the last 5 years, with Q4 2016 value amounting to $245.0 million.

  • Abbott Laboratories' Liabilities from Discontinued Operations fell 3431.64% to $245.0 million in Q4 2016 from the same period last year, while for Dec 2016 it was $245.0 million, marking a year-over-year decrease of 3431.64%. This contributed to the annual value of $245.0 million for FY2016, which is 3431.64% down from last year.
  • Abbott Laboratories' Liabilities from Discontinued Operations amounted to $245.0 million in Q4 2016, which was down 3431.64% from $597.0 million recorded in Q3 2016.
  • In the past 5 years, Abbott Laboratories' Liabilities from Discontinued Operations ranged from a high of $721.0 million in Q3 2014 and a low of $169.0 million during Q1 2014
  • Moreover, its 4-year median value for Liabilities from Discontinued Operations was $352.2 million (2013), whereas its average is $375.2 million.
  • Its Liabilities from Discontinued Operations has fluctuated over the past 5 years, first soared by 10688.67% in 2014, then crashed by 5062.41% in 2015.
  • Over the past 4 years, Abbott Laboratories' Liabilities from Discontinued Operations (Quarter) stood at $386.0 million in 2013, then skyrocketed by 76.17% to $680.0 million in 2014, then plummeted by 45.15% to $373.0 million in 2015, then plummeted by 34.32% to $245.0 million in 2016.
  • Its Liabilities from Discontinued Operations was $245.0 million in Q4 2016, compared to $597.0 million in Q3 2016 and $361.0 million in Q2 2016.